Kerala Ayurveda Limited has submitted its quarterly compliance certificate to BSE Limited, fulfilling regulatory requirements under SEBI (Depositories and Participants) Regulations, 2018. The certificate pertains to the quarter ended March 31, 2026, and was filed on April 2, 2026.

Regulatory Compliance Details

The certificate was issued under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018, by Integrated Registry Management Services Private Ltd., which serves as the company's Registrar and Share Transfer Agent. This quarterly filing is a mandatory requirement for listed companies to ensure transparency in their dematerialization processes.

Certificate Confirmation

Integrated Registry Management Services Private Ltd. confirmed that all securities received from Depository Participants for dematerialization during the quarter were properly processed. The registrar verified that:

• Securities received for dematerialization were confirmed to depositories and stock exchanges
• All security certificates were mutilated and cancelled after verification
• Depository names were substituted in the register of members as registered owners within the stipulated 15-day period

Corporate Information

The filing was digitally signed by George K T, Chief Financial Officer and Designated Officer for filing, on April 6, 2026. Kerala Ayurveda Limited operates as an ISO 9001:2015 certified company with its registered office in Ernakulam, Kerala, and corporate office in Bengaluru.

This compliance filing demonstrates the company's adherence to regulatory requirements and maintains transparency in its share transfer and dematerialization processes for stakeholders.

Kerala ayurveda Limited has announced the closure of its trading window for designated persons and their immediate relatives, effective from March 31, 2026. The closure will remain in effect until 48 hours after the company announces its audited financial results for the quarter and year ending March 31, 2026.

Regulatory Compliance

The trading window closure is implemented in compliance with the Securities and Exchange Board of India (Prohibition of Insider Trading) Regulations, 2015, including any amendments. The measure also aligns with the company's internal "Code of Conduct for Regulating, Monitoring, Preventing and Reporting of Trading in Securities by Insiders and Designated Persons and Immediate Relatives of Designated Persons."

Additional Regulatory Measures

Pursuant to SEBI circular no. SEBI/HO/ISD/ISD-PoD-2/P/CIR/2025/55 dated April 21, 2025, the PAN of designated persons and their immediate relatives will be frozen by Central Depository Services (India) Limited during the window closure period. This measure serves as an additional safeguard to prevent insider trading during the sensitive period leading up to the financial results announcement.

Board Meeting Schedule

The company has indicated that the date of the Board of Directors meeting to approve the financial results for the quarter and year ending March 31, 2026, will be communicated separately in due course. The trading window will reopen 48 hours after the official announcement of these audited financial results.

The notification was signed by George K T, Chief Financial Officer and Compliance Officer of Kerala Ayurveda Limited, on March 26, 2026. The company maintains its registered office in Ernakulam, Kerala, and corporate office in Bengaluru, Karnataka.